Sucralfate and soluble sucrose octasulfate bind and stabilize acidic fibroblast growth factor.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Biochimica et Biophysica Acta

• Publication date

  1993-11-10

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0167-4838(93)90031-LPMID 7692970
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Three-dimensional structures of acidic and basic fibroblast growth factors.

  1993cited by this paper
• Effect of polyanions on the unfolding of acidic fibroblast growth factor.

  1993cited by this paper
• Determination of protein secondary structure by Fourier transform infrared spectroscopy: a critical assessment.

  1993cited by this paper
• Physical stabilization of acidic fibroblast growth factor by polyanions.

  1993cited by this paper
• Nature of the interaction of heparin with acidic fibroblast growth factor.

  1993cited by this paper
• Formulation Design of Acidic Fibroblast Growth Factor

  1993cited by this paper
• Reduction of bacterial translocation with oral fibroblast growth factor and sucralfate.

  1993cited by this paper
• Nature of the interaction of growth factors with suramin.

  1992cited by this paper
• Binding of heparin to basic fibroblast growth factor induces a conformational change.

  1992cited by this paper
• β-II conformation of all-β proteins can be distinguished from unordered form by circular dichroism

  1992cited by this paper
• Role of sucralfate in peptic disease.

  1992cited by this paper
• Beta-II conformation of all-beta proteins can be distinguished from unordered form by circular dichroism.

  1992cited by this paper
• Acidic fibroblast growth factor accelerates the healing of acetic-acid-induced gastric ulcers in rats.

  1992cited by this paper
• The effects of surface adsorption on the thermal stability of proteins

  1992cited by this paper
• Growth factors in the gastrointestinal tract.

  1992cited by this paper
• Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells

  1992cited by this paper
• Sucralfate induces proliferation of dermal fibroblasts and keratinocytes in culture and granulation tissue formation in full-thickness skin wounds

  1991cited by this paper
• The mode of action of sucralfate: the 1 x 1 x 1 mechanism of action.

  1991cited by this paper
• Conversion of cysteine to serine residues alters the activity, stability, and heparin dependence of acidic fibroblast growth factor.

  1991cited by this paper
• The structure of human acidic fibroblast growth factor and its interaction with heparin.

  1991cited by this paper
• Effect of polyanions on the refolding of human acidic fibroblast growth factor.

  1991cited by this paper
• Structure‐Function Studies of Acidic Fibroblast Growth Factor a

  1991cited by this paper
• Duodenal ulcer : discovery of a new mechanism and development of angiogenic therapy that accelerates healing

  1991cited by this paper
• Role of vascular factors, including angiogenesis, in the mechanisms of action of sucralfate.

  1991cited by this paper
• Sucralfate.

  1991cited by this paper
• Structure-function studies of acidic fibroblast growth factor.

  1991cited by this paper
• Effect of Epidermal Growth Factor in Combination with Sucralfate or Omeprazole on the Healing of Chronic Gastric Ulcers in the Rat

  1990cited by this paper
• The protective and therapeutic mechanisms of sucralfate.

  1990cited by this paper
• Measuring and increasing protein stability.

  1990cited by this paper
• Fibroblast growth factor. Chemical structure and biologic function.

  1990cited by this paper
• Disulfide bonds are neither required, present, nor compatible with full activity of human recombinant acidic fibroblast growth factor.

  1990cited by this paper
• Measuring and increasing protein stability

  1990cited by this paper
• Evidence of anti-oxidant role of sucralfate in gastric mucosal protection.

  1990cited by this paper
• Epidermal growth factor in the gastroprotective and ulcer-healing actions of sucralfate in rats.

  1989cited by this paper
• The heparin-binding (fibroblast) growth factor family of proteins.

  1989cited by this paper
• Pathways of gastrointestinal protection and repair: mechanisms of action of sucralfate.

  1989cited by this paper
• A differential scanning calorimetric study of the bovine lens crystallins.

  1989cited by this paper
• Expression in Escherichia coli of a Chemically Synthesized Gene for Biologically Active Bovine Acidic Fibroblast Growth Factor

  1987cited by this paper
• Patterns of Recurrence in Relation to Therapeutic Strategy in Gastric Cancer

  1987cited by this paper
• Purification and characterization of acidic fibroblast growth factor from bovine brain.

  1984cited by this paper

• Developments in the management of diabetic foot ulcers (Review)

  2025cites this paper
• Sucralfate Prevents Pin Site Infections of External Fixators in Open Tibia Fractures.

  2024cites this paper
• Effect of TLC-NOSF Dressing on Epithelization of Diabetic Wounds: A Pilot Clinical Trial

  2024cites this paper
• A double-network porous hydrogel based on high internal phase emulsions as a vehicle for potassium sucrose octasulfate delivery accelerates diabetic wound healing

  2024cites this paper
• Formulation and evaluation of emulgel containing Sucralfate and Dimethicone; A novel transdermal pharmaceutical dosage form

  2022cites this paper
• Effectiveness of Sucrose Octasulfate Dressing in the Treatment of Neuro-Ischaemic Diabetic Foot Heel Ulcers: A Retrospective Single arm Study

  2022cites this paper
• CAN SUCRALFATE ENEMA PREVENT COLITIS IN COLONIC SEGMENTS WITHOUT FECAL TRANSIT?

  2022cites this paper
• Retinoschisin and novel Na/K-ATPase interaction partners Kv2.1 and Kv8.2 define a growing protein complex at the inner segments of mammalian photoreceptors

  2022cites this paper
• New Evidence-Based Therapies for Complex Diabetic Foot Wounds

  2022cites this paper
• ENEMA DE SULCRALFATO PODE PREVENIR COLITE EM SEGMENTOS COLÔNICOS SEM TRÂNSITO FECAL?

  2021cites this paper
• Clinical evaluation of polyabsorbent TLC-NOSF dressings on chronic wounds: a prospective, observational, multicentre study of 1140 patients.

  2020cites this paper
• Managing Diabetic Foot Ulcers: Pharmacotherapy for Wound Healing

  2020cites this paper
• Impact of wound duration on diabetic foot ulcer healing: evaluation of a new sucrose octasulfate wound dressing.

  2020cites this paper
• Effectiveness of Topical Sucralfate in the Management of Pressure Ulcer in Hospitalized Patients: A Prospective, Randomized, Placebo-Controlled Trial

  2019cites this paper
• Optimal wound closure of diabetic foot ulcers with early initiation of TLC-NOSF treatment: post-hoc analysis of Explorer.

  2019cites this paper
• Identifying and treating foot ulcers in patients with diabetes: saving feet, legs and lives.

  2018cites this paper
• Inhibition of the BMP pathway prevents development of Barrett’s-associated adenocarcinoma in a surgical rat model

  2017cites this paper
• Ex Situ and In Situ Characterization of Vaccine Suspensions in Pre-Filled Syringes.

  2017cites this paper
• Sucrose octasulfate dressing versus control dressing in patients with neuroischaemic diabetic foot ulcers (Explorer): an international, multicentre, double-blind, randomised, controlled trial.

  2017cites this paper
• Efficacy of 10% sucralfate ointment after anal fistulotomy: A prospective, double-blind, randomized, placebo-controlled trial.

  2016cites this paper
• Evaluation of the anti-inflammatory and antioxidant effects of the sucralfate in diversion colitis

  2015cites this paper
• Tissue content of sulfomucins and sialomucins in the colonic mucosa, without fecal stream, undergoing daily intervention with sucralfate.

  2015cites this paper
• MODELS, BIOLOGICAL Tissue content of sulfomucins and sialomucins in the colonic mucosa, without fecal stream, undergoing daily intervention with sucralfate 1

  2015cites this paper
• High-potency sucralfate prevents and rapidly reverses chemo-radiation mucositis in a patient with stage 4b head and neck cancer

  2013cites this paper
• Evaluation of sucralfate enema in experimental diversion colitis

  2013cites this paper
• Reverse-phase Ion-Pairing Ultra Performance Liquid Chromatography-Mass Spectrometry In Characterization And Fingerprinting Of Diverse Sulfated Glycosaminoglycan Mimetics

  2013cites this paper
• Comparison of high-throughput biophysical methods to identify stabilizing excipients for a model IgG2 monoclonal antibody: conformational stability and kinetic aggregation measurements.

  2012cites this paper
• Facilitated diffusion of VEGF165 through descemet's membrane with sucrose octasulfate

  2012cites this paper
• Interactions of formulation excipients with proteins in solution and in the dried state.

  2011cites this paper
• Topical Sucralfate Treatment of Anal Fistulotomy Wounds: A Randomized Placebo-Controlled Trial

  2011cites this paper
• Protein-excipient interactions: mechanisms and biophysical characterization applied to protein formulation development.

  2011cites this paper
• Sucrose Octasulfate Selectively Accelerates Thrombin Inactivation by Heparin Cofactor II*

  2010cites this paper
• Crystal structures of aprotinin and its complex with sucrose octasulfate reveal multiple modes of interactions with implications for heparin binding.

  2010cites this paper
• Topical use of sucralfate in epithelial wound healing: clinical evidences and molecular mechanisms of action.

  2010cites this paper
• A surface plasmon resonance-based solution affinity assay for heparan sulfate-binding proteins

  2009cites this paper
• The complex inter-relationships between protein flexibility and stability.

  2008cites this paper
• The interaction of heparin/polyanions with bovine, porcine, and human growth hormone.

  2008cites this paper
• Topical treatment of chronic venous ulcers with sucralfate: a placebo controlled randomized study.

  2008cites this paper
• Sucrose chemistry and applications of sucrochemicals.

  2007cites this paper
• Alleviation of Experimental Ulcerative Colitis with the Synthetic Peptide, F2A4-K-NS (Fibratide)

  2007cites this paper
• Parathyroid hormone is a heparin/polyanion binding protein: Binding energetics and structure modification

  2007influential citation
• Aluminium, Tau and Alzheimer's Disease

  2007cites this paper
• EFFECTS OF SUCRALFATE, CIMETIDINE AND RABEPRAZOLE ON MUCOSAL HYDROXYPROLINE CONTENT IN HEALING OF ETHANOL–HCL‐INDUCED GASTRIC LESIONS

  2006cites this paper
• Conformational flexibility, hydration and state parameter fluctuations of fibroblast growth factor-10: effects of ligand binding.

  2006cites this paper
• Structural basis for fibroblast growth factor receptor activation.

  2005cites this paper
• Inhibitors of cytochrome P450 4A suppress angiogenic responses.

  2005cites this paper
• Polyanions and the Proteome*

  2004cites this paper
• Symmetric primary and tertiary structure mutations within a symmetric superfold: a solution, not a constraint, to achieve a foldable polypeptide.

  2004cites this paper
• Optimization of cancer chemotherapy: local delivery of paclitaxel and pharmacokinetics of suramin

  2004cites this paper
• Molecular cloning, overexpression, and characterization of the ligand-binding D2 domain of fibroblast growth factor receptor.

  2004cites this paper
• Rational Design of Stable Protein Formulations

  2002cites this paper
• High throughput formulation: strategies for rapid development of stable protein products.

  2002cites this paper
• Structure and Stability of an Acidic Fibroblast Growth Factor from Notophthalmus viridescens * 210

  2002cites this paper
• Characterization of the Structure and Dynamics of a Near-native Equilibrium Intermediate in the Unfolding Pathway of an All β-Barrel Protein*

  2002cites this paper
• Characterization of the structure and dynamics of a near-native equilibrium intermediate in the unfolding pathway of an all beta-barrel protein.

  2002cites this paper
• Binding of Sucrose Octasulphate to the C‐Type Lectin‐Like Domain of the Recombinant Natural Killer Cell Receptor NKR‐P1A Observed by NMR Spectroscopy

  2002cites this paper
• Structural Basis for Activation of Fibroblast Growth Factor Signaling by Sucrose Octasulfate

  2002cites this paper
• Oligomerization of acidic fibroblast growth factor is not a prerequisite for its cell proliferation activity

  2002influential citation
• 15N NMR Relaxation Studies of Free and Ligand-bound Human Acidic Fibroblast Growth Factor*

  2000cites this paper
• Identification and dynamics of a heparin-binding site in hepatocyte growth factor.

  1999cites this paper
• A basic compositional requirement of agents having heparin-like cell-modulating activities.

  1997cites this paper
• Demonstration of Sucralfate-mediated Preservation of Growth Factor Bioactivity in the Presence of Low pH with a Human Gastric Epithelial Cell Line (AGS)

  1996cites this paper
• Functions of fibroblast growth factors (FGFs) in the nervous system

  1996cites this paper
• The characterization, stabilization, and formulation of acidic fibroblast growth factor.

  1996cites this paper
• Evaluation of antiulcer agents with a human adenocarcinoma cell line (AGS)

  1996cites this paper
• Conformational analysis of sucrose octasulfate by high resolution nuclear magnetic resonance spectroscopy.

  1995cites this paper
• Relationship between gastroprotective effect of locally acting antiulcer agent ecabet sodium and its binding to gastric mucosa in rats

  1995cites this paper
• Cell surface binding and cellular internalization properties of suramin, a novel antineoplastic agent.

  1995cites this paper